Indrayani Biotech intimates BSE of ISIN details for its partly paid-up rights entitlement equity shares.
The rights issue was approved by the Right Issue Committee on April 9, 2026, with face value ₹10 and paid-up value ₹2.50.
ISIN INE007C20013 assigned for rights entitlement shares under SEBI ICDR Regulations 2018 compliance.
Disclosure uploaded to company website and submitted for BSE record as per regulatory requirements.